Efficacy of statins in preventing anthracycline-induced cardiotoxicity in individuals with breast cancer: a systematic review and meta-analysis
The Journal of Clinical Oncology · 24.10.2025 · 13 (1)
DOI: 10.52338/tjoco.2025.4970 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift The Journal of Clinical Oncology, online erschienen am 24.10.2025. Verfasst von Internal Medicine und 1 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Anthracyclines are standard chemotherapeutic agents for breast cancer but may cause dose-dependent, irreversible myocardial damage (class I cardiotoxicity) via reactive oxygen species (ROS), potentially leading to dilated cardiomyopathy and heart failure. Statins, through their pleiotropic effects, reduce oxidative stress and inflammation, offering cardioprotection. This meta-analysis evaluates the impact of statins on cardiac dysfunction, LVEF, LVESV, LVEDV, and LA diameter in women with breast cancer receiving anthracycline-based chemotherapy.
Methods
PubMed, Google Scholar, and Cochrane Library were searched through February 11, 2025, for randomized controlled trials and propensity-matched observational studies comparing statins with placebo in breast cancer patients on anthracyclines. Outcomes included changes in cardiac dysfunction, LVEF, LVESV, LVEDV, and LA diameter. A review manager was used to analyze data as mean differences with 95% confidence intervals (CI).
Results
A total of 428 patients were included; 180 (42%) in the statin group and 248 (58%) in the placebo group. Statin users had a significantly lower risk of cardiac dysfunction (RR=0.41 [95% CI: 0.23–0.72], P=0.02, I²=0%). They also had reduced LVEF decline (MD= -3.42 [CI: -5.10 to -1.73], P
Zitieren
APA
Medicine, I., & Center, B. M. (2025). Efficacy of statins in preventing anthracycline-induced cardiotoxicity in individuals with breast cancer: a systematic review and meta-analysis. The Journal of Clinical Oncology, 13(1). https://doi.org/10.52338/tjoco.2025.4970
Vancouver
Medicine I, Center BM. Efficacy of statins in preventing anthracycline-induced cardiotoxicity in individuals with breast cancer: a systematic review and meta-analysis. The Journal of Clinical Oncology. 2025;13(1). doi:10.52338/tjoco.2025.4970
BibTeX
@article{Medicine2025,
author = {Medicine, Internal and Center, Bayhealth Medical},
title = {Efficacy of statins in preventing anthracycline-induced cardiotoxicity in individuals with breast cancer: a systematic review and meta-analysis},
journal = {The Journal of Clinical Oncology},
year = {2025},
volume = {13},
number = {1},
doi = {10.52338/tjoco.2025.4970}
}
EUVIMED